Did you know that AstraZeneca, manufacturer of two blockbuster breast cancer drugs (one of which is classified as a known human carcinogen), was the originator of Breast Cancer Awareness Month?
Why is it, do you think, that during Breast Cancer Awareness Month (BCAM) you never hear the word “carcinogen” mentioned, but are barraged a million times over by the word “cure”?
Truth be told, BCAM should be renamed Breast Cancer Un-Awareness Month, as it has very little to nothing to do with generating awareness about the true causes and solutions for the breast cancer epidemic and everything to do with making the public focus on a presumably not-yet-existent “cure” to be produced through the pharmaceutical pipeline somewhere off in the future only after enough money is raised.
Instead of identifying and addressing the known causes of cancer, like the many mammary carcinogens now identified in body care products, GMO and processed foods, and our polluted environment, the mission of BCAM is to make people think that the best way to prevent breast cancer is to “detect it early.”
And how?
By subjecting their breasts to radiation-based diagnostic screening that we now know actually causes breast cancer, and which has lead to over one million cases of falsely diagnosed and unnecessarily treated breast cancers in the past 30 years in U.S. women alone. One recent review on the topic of mammography concluded that they are harmful and should be avoided, and yet you will hear countless messages this month that breast screenings are safe and effective for reducing breast cancer mortality — technically, a lie.
Read more: Covering Up The Causes of Breast Cancer Since 1985: AstraZeneca’s BCAM
